{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T22:42:01Z","timestamp":1772664121579,"version":"3.50.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"MA Karsdal"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomark. Med."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.2217\/bmm.15.119","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T14:52:08Z","timestamp":1452783128000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["CRP and a Biomarker of type I Collagen Degradation, C1M, Can Differentiate Anti-Inflammatory Treatment Response in Ankylosing Spondylitis"],"prefix":"10.1080","volume":"10","author":[{"given":"Anne Sofie","family":"Siebuhr","sequence":"first","affiliation":[{"name":"Nordic Bioscience, Biomarkers & Research,\rHerlev Hovedgade 207,\rHerlev\rDK-2730,\rDenmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C","family":"Bay-Jensen","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, Biomarkers & Research,\rHerlev Hovedgade 207,\rHerlev\rDK-2730,\rDenmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[{"name":"Nordic Bioscience, Biomarkers & Research,\rHerlev Hovedgade 207,\rHerlev\rDK-2730,\rDenmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik J","family":"Lories","sequence":"additional","affiliation":[{"name":"Skeletal Biology & Engineering Research Center, KU Leuven & Division of Rheumatology, UZ Leuven,\rHerestraat 49,\rB-3000\rLeuven,\rBelgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"de Vlam","sequence":"additional","affiliation":[{"name":"Skeletal Biology & Engineering Research Center, KU Leuven & Division of Rheumatology, UZ Leuven,\rHerestraat 49,\rB-3000\rLeuven,\rBelgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21054"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2010.05.005"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2011.620628"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4266"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.01.001"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.07.008"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054504"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.04.004"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-11-6"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.4137\/BMI.S6347"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02309.x"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138883"},{"issue":"10","key":"e_1_3_3_15_1","first-page":"2030","article-title":"Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis","volume":"35","author":"Maksymowych WP","year":"2008","unstructured":"Maksymowych WP , RahmanP, ShojaniaKet al. Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis. J. Rheumatol.35(10), 2030\u20132037 (2008).","journal-title":"J. Rheumatol."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2237-8"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30627"},{"issue":"9","key":"e_1_3_3_18_1","first-page":"1751","article-title":"Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept","volume":"32","author":"Davis JC","year":"2005","unstructured":"Davis JC Jr , van der HeijdeDM, DougadosMet al. Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept. J. Rheumatol.32(9), 1751\u20131754 (2005).","journal-title":"J. Rheumatol."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016386"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24838"},{"issue":"3","key":"e_1_3_3_21_1","first-page":"371","article-title":"Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis","volume":"30","author":"Skjot-Arkil H","year":"2012","unstructured":"Skjot-Arkil H , SchettG, ZhangCet al. Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis. Clin. Exp. Rheumatol.30(3), 371\u2013379 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041137"},{"issue":"8","key":"e_1_3_3_23_1","first-page":"1753","article-title":"Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept","volume":"34","author":"Woo JH","year":"2007","unstructured":"Woo JH , LeeHJ, SungIH, KimTH. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. J. Rheumatol.34(8), 1753\u20131759 (2007).","journal-title":"J. Rheumatol."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.148890"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3369"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060513488501"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203559"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38856"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.9.799"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(89)90358-6"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02284058"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.2.288"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken148"},{"issue":"10","key":"e_1_3_3_34_1","first-page":"1911","article-title":"Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis","volume":"32","author":"Maksymowych WP","year":"2005","unstructured":"Maksymowych WP , PooleAR, HiebertLet al. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J. Rheumatol.32(10), 1911\u20131917 (2005).","journal-title":"J. Rheumatol."},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.40"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm.15.119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:13Z","timestamp":1719124813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm.15.119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.2217\/bmm.15.119"],"URL":"https:\/\/doi.org\/10.2217\/bmm.15.119","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"value":"1752-0363","type":"print"},{"value":"1752-0371","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}